FDA cites higher death risk in Sanofi drug study
(AP) -- Federal health regulators are warning doctors that a heart drug from Sanofi was associated with fatal heart problems in a recently halted company study.
The Food and Drug Administration reported Thursday that Sanofi halted a trial of its drug Multaq after there were twice as many heart attacks, strokes and deaths among patients taking the drug compared with patients taking placebo.
Among more than 3,000 patients studied, there were 32 cardiovascular deaths in the Multaq group compared with 14 in the placebo group.
The study involved patients older than 65 with a permanent heart condition known as atrial fibrillation which causes the heart's chambers to pump out of sync. The FDA approved the drug in 2009 for the short-term form of the condition and a related condition known as atrial flutter. However, doctors routinely prescribe drugs for uses other than those listed on the label.
About 241,000 U.S. patients had received a prescription for the twice-a-day pill as of last month.
The FDA said it is still reviewing the trial data and advises patients taking Multaq to talk with their doctor.
Sanofi, based in Paris, said in a statement it still considers the drug beneficial to patients.
"It is important that Multaq only be used in patients with non-permanent atrial fibrillation or atrial flutter, as per the current U.S. label," a company spokesman said in an email.
The European Medicines Agency is also reviewing the safety of Multaq.
In midday trading, U.S.-listed shares of Sanofi added 5 cents to $39.75.
©2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- FDA warns of liver damage reports with Sanofi drug Jan 14, 2011 | not rated yet | 0
- New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers Apr 05, 2010 | not rated yet | 0
- New anti-clotting drug added to recommendations for treating irregular heartbeat Feb 14, 2011 | not rated yet | 0
- FDA adds heart warning to Pfizer anti-smoking pill Jun 16, 2011 | not rated yet | 0
- Common painkillers linked to irregular heart rhythm: study Jul 04, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
9 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications 19 hours ago | not rated yet | 0
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications 21 hours ago | not rated yet | 0
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications May 22, 2013 | not rated yet | 0
The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
Medications May 22, 2013 | not rated yet | 0
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
11 minutes ago | not rated yet | 0 |
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
2 minutes ago | not rated yet | 0 |
A new study determined that children and adolescents with seizures involving the temporal lobe are likely to have clinically significant behavioral problems and psychiatric illness, especially depression. Findings published ...
13 minutes ago | not rated yet | 0
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
1 hour ago | 4.7 / 5 (3) | 0 |
As the human body fine-tunes its neurological wiring, nerve cells often must fix a faulty connection by amputating an axon—the "business end" of the neuron that sends electrical impulses to tissues or other ...
1 hour ago | 5 / 5 (1) | 0 |
Scientists have uncovered a survival mechanism that occurs in breast cells that have just turned premalignant-cells on the cusp between normalcy and cancers-which may lead to new methods of stopping tumors.
1 hour ago | not rated yet | 0 |